Impax Laboratories, Hayward, CA

Impax Laboratories

www.impaxlabs.com

Impax Laboratories is a technology-based specialty pharmaceutical company utilizing our core competency in drug delivery and formulation expertise. We have a balanced business model consisting of a successful generic business targeting high-value solid oral and alternative dosage form Abbreviated New Drug Applications (ANDA), and a branded business currently focused on internally developing Central Nervous System (CNS) products where we can deliver meaningful patient benefits and develop strong intellectual property positions.

Number of Employees: 1K-5K
Annual Revenue: $500M-1 Billion

www.impaxlabs.com
30831 Huntwood Ave.
Hayward, CA USA 94544
Phone: 510.240.6000

Name	Title	Contact Details
Laman Alani	VP Product Development	Profile
Todd Engle	VP, Sales and Marketing	Profile
Todd Engle	VP, Sales and Marketing	Profile
Steve Flint	Director - Human Resources	Profile
Donna Hughes	Senior Vice President of Human Resources	Profile

Similar Companies

Revive Therapeutics

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.

Terns Pharmaceuticals

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.

HR Execs on the Move